Simon Guile
15Patents
5h-index
13Co-inventors
59Inventor score
Filing activity: Sep 21, 1998 → Dec 21, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6525060B1 | Triazolo(4,5-d)pyrimidine compounds | Chemistry; Metallurgy | 20 | Expired |
| US6251910A | 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists | Human Necessities | 14 | Expired |
| US7064126B2 | Compounds | Human Necessities | 6 | Expired |
| US6974868B2 | Compounds | Chemistry; Metallurgy | 6 | Expired |
| US7250419B2 | Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition | Chemistry; Metallurgy | 6 | Expired |
| US6713483B1 | [1,2,3]-triazolo[4,5-d] pyrimidine compounds | Human Necessities | 5 | Expired |
| US7964616B2 | Compounds 679 | Chemistry; Metallurgy | 2 | Active |
| US7384950B2 | Thienopyrimidinediones and their use in the modulation of autoimmune disease | Human Necessities | 1 | Expired |
| US7034032B2 | Cyclopentan-2-ol-1-yl-[1,2,3]triazolo[4,5-D]pyrimidine compounds | Human Necessities | 1 | Expired |
| US7345047B2 | Substituted [1,2,3]triazolo[4,5-d]pyrimidines | Human Necessities | 0 | Expired |
| USRE46276E1 | Triazolo(4,5-D)pyrimidine compounds | General | 0 | Active |
| US7393854B2 | Thienopyrimidinedinones and their use in modulation of autoimmune disease | Human Necessities | 0 | Expired |
| US7384951B2 | Thienopyrimidinediones and their use in the modulation of autoimmune disease | Human Necessities | 0 | Expired |
| US8106073B2 | Quinoline derivatives 057 | Human Necessities | 0 | Active |
| US6844348B2 | 2,3,4-cyclopentan-2,3,4-triol-1-yl compounds | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.